![]() ![]() This is a multicenter retrospective analysis of pathological T1 non-small cell lung cancer patients who underwent surgical resection from 2 January 2014 to 27 December 2017. However, the clinical characteristics of patients with lymph node metastasis in China are not fully understood. 13 Medical Affairs, Linkdoc Technology Co, Ltd, Beijing, China.Īpproximately 8.3-15.9% of patients with clinical stage I non-small cell lung cancer are subsequently shown to have lymph node metastasis.12 Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.11 Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.10 Department of Thoracic Surgery, Henan Cancer Hospital, Zhengzhou, China.9 Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.8 Department of Thoracic Surgery, First Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, China.7 Department of Thoracic Surgery, Chinese People's Liberation Army General Hospital, Beijing, China.6 Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.5 Department of Thoracic Surgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.4 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China.3 Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.2 Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province, Nanjing, China.1 Department of Thoracic Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.LinkDoc just received a strategic investment from Alibaba Health on March 4 and secured 700 million yuan in the series D+ financing round led by CICC Capital last year. Last year, Burning Rock Biotech Ltd and Genetron Health, two leading companies in China's tumor genetic testing industry, also went public on Nasdaq. Its services are used in hospitals, clinics, pharmaceutical companies, and government administrations, which include the Chinese Medical Doctor Association, and the China Society of Clinical Oncology, among others.Ĭontext: Since the outbreak of the pandemic, the biotechnology sector represented by precision medicine has become a highly sought-after industry in the secondary market. LinkDoc’s revenue increased by 40.8% from 158.5 million yuan for the three months ended March 31, 2020, to 223.2 million yuan ($34.1 million) for the three months ended March 31, 2021.įounded in 2014 in Beijing by Shan He and Tony Zhang, LinkDoc offers a repository of big data for the healthcare industry such as clinical trials, AI diagnosis, and management. Citing sources, Bloomberg reported last month that LinkDoc was eying to raise $500 million in IPO. The company said the proceeds of the IPO will be used to strengthen its research and development capabilities, investment, and acquisitions. LinkDoc Technology Ltd, a medical data company backed by Alibaba's health subsidiary, filed for an initial public offering in the US on Monday.ĭetails: In the F-1 filling submitted to the US Securities and Exchange Commission, the company stated that it plans to list its American depositary shares on Nasdaq under the symbol "LDOC". Alibaba-backed medical data company LinkDoc files for US IPO - PingWest English 中文Īlibaba-backed medical data company LinkDoc files for US IPO J2:28 am ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |